These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1627020)

  • 1. The Lipid Research Clinics Coronary Primary Prevention Trial. Results of 6 years of post-trial follow-up. The Lipid Research Clinics Investigators.
    Arch Intern Med; 1992 Jul; 152(7):1399-410. PubMed ID: 1627020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of cholesterol reduction with cholestyramine on renal function.
    Kshirsagar AV; Shoham DA; Bang H; Hogan SL; Simpson RJ; Colindres RE
    Am J Kidney Dis; 2005 Nov; 46(5):812-9. PubMed ID: 16253720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease.
    JAMA; 1984 Jan; 251(3):351-64. PubMed ID: 6361299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Lipid Research Clinics Coronary Primary Prevention Trial: results and implications.
    Rifkind BM
    Monogr Atheroscler; 1985; 13():74-84. PubMed ID: 3911061
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group.
    Neaton JD; Blackburn H; Jacobs D; Kuller L; Lee DJ; Sherwin R; Shih J; Stamler J; Wentworth D
    Arch Intern Med; 1992 Jul; 152(7):1490-500. PubMed ID: 1627030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary prevention clinics for coronary heart disease: a 10-year follow-up of a randomised controlled trial in primary care.
    Delaney EK; Murchie P; Lee AJ; Ritchie LD; Campbell NC
    Heart; 2008 Nov; 94(11):1419-23. PubMed ID: 18198203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholesterol-lowering therapy after heart transplantation: a 12-month randomized trial.
    Pflugfelder PW; Huff M; Oskalns R; Rudas L; Kostuk WJ
    J Heart Lung Transplant; 1995; 14(4):613-22. PubMed ID: 7578166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of long-term cholestyramine administration on vitamin D and parathormone levels in middle-aged men with hypercholesterolemia.
    Hoogwerf BJ; Hibbard DM; Hunninghake DB
    J Lab Clin Med; 1992 Apr; 119(4):407-11. PubMed ID: 1583392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Lipid Research Clinics Coronary Primary Prevention Trial.
    Rifkind BM
    Drugs; 1986; 31 Suppl 1():53-60. PubMed ID: 3720571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary prevention of coronary heart disease with drug therapy. Safety and total mortality issues.
    Grundy SM
    Arch Intern Med; 1992 Jul; 152(7):1369-71. PubMed ID: 1627015
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of secondary prevention clinics on health status in patients with coronary heart disease: 4 year follow-up of a randomized trial in primary care.
    Murchie P; Campbell NC; Ritchie LD; Deans HG; Thain J
    Fam Pract; 2004 Oct; 21(5):567-74. PubMed ID: 15367480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gemfibrozil in the treatment of dyslipidemia: an 18-year mortality follow-up of the Helsinki Heart Study.
    Tenkanen L; Mänttäri M; Kovanen PT; Virkkunen H; Manninen V
    Arch Intern Med; 2006 Apr; 166(7):743-8. PubMed ID: 16606810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
    Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
    Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Statins in primary prevention of coronary heart disease].
    Paulweber B
    Wien Med Wochenschr; 1999; 149(5-6):129-38. PubMed ID: 10408004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of xuezhikang on cardiovascular events and mortality in elderly patients with a history of myocardial infarction: a subgroup analysis of elderly subjects from the China Coronary Secondary Prevention Study.
    Ye P; Lu ZL; Du BM; Chen Z; Wu YF; Yu XH; Zhao YC;
    J Am Geriatr Soc; 2007 Jul; 55(7):1015-22. PubMed ID: 17608873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid Research Clinics Coronary Primary Prevention Trial: results and implications.
    Rifkind BM
    Am J Cardiol; 1984 Aug; 54(5):30C-34C. PubMed ID: 6382999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of gemfibrozil in the primary prevention of atrial fibrillation in a large randomized controlled trial.
    Adabag AS; Mithani S; Al Aloul B; Collins D; Bertog S; Bloomfield HE;
    Am Heart J; 2009 May; 157(5):913-8. PubMed ID: 19376321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
    Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J
    Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NHLBI workshop on the Lipid Research Clinics Coronary Primary Prevention Trial.
    Arteriosclerosis; 1985; 5(4):397-403. PubMed ID: 3893403
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative efficacy and safety of pravastatin and cholestyramine alone and combined in patients with hypercholesterolemia. Pravastatin Multicenter Study Group II.
    Arch Intern Med; 1993 Jun; 153(11):1321-9. PubMed ID: 8507122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.